These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2136816)

  • 1. Are there markers of the blood-vessel wall interaction and of thrombus formation that can be used clinically?
    Gershlick AH
    Circulation; 1990 Jan; 81(1 Suppl):I28-34; discussion I40-1. PubMed ID: 2136816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of automation on the quantitation of low molecular weight markers of hemostatic defects.
    Fareed J; Walenga JM; Bick RL; Bermes EJ; Messmore HL
    Semin Thromb Hemost; 1983 Oct; 9(4):355-79. PubMed ID: 6229030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelets, blood flow, and the vessel wall.
    Mustard JF; Packham MA; Kinlough-Rathbone RL
    Circulation; 1990 Jan; 81(1 Suppl):I24-7; discussion I40-1. PubMed ID: 2403865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.
    Zwaginga JJ; Koomans HA; Sixma JJ; Rabelink TJ
    J Clin Invest; 1994 Jan; 93(1):204-11. PubMed ID: 8282789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet activation and allergic asthma.
    Gresele P; Todisco T; Merante F; Nenci GG
    N Engl J Med; 1982 Mar; 306(9):549. PubMed ID: 6173752
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet markers of thromboembolic disease.
    Wohl H
    West J Med; 1981 Jul; 135(1):19-24. PubMed ID: 6167074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanisms of acute coronary syndrome].
    Lüscher TF; Wenzel RR
    Praxis (Bern 1994); 1995 Feb; 84(6):155-64. PubMed ID: 7871298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet function in sickle cell disease during steady state.
    Triadou P; Fonty E; Ambrosio AS; Cottat MC; Girot R; Cornu P
    Nouv Rev Fr Hematol (1978); 1990; 32(2):137-42. PubMed ID: 2143013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular markers of hemostatic activation in atherosclerosis: a new concept in diagnostic profiling of endogenous pathophysiologic transition.
    Fareed J; Walenga JM; Baker WH; Hayes A; Hoppensteadt DA
    Semin Thromb Hemost; 1986 Apr; 12(2):102-9. PubMed ID: 2943019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet activation during steady state sickle cell disease.
    Westwick J; Watson-Williams EJ; Krishnamurthi S; Marks G; Ellis V; Scully MF; White JM; Kakkar VV
    J Med; 1983; 14(1):17-36. PubMed ID: 6224876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Warning: platelet factor 4, beta-thromboglobulin and thromboxane in donor's plasma units.
    Stratta P; Canavese C; Peiretti F; Vallauri P; Vercellone A
    Thromb Haemost; 1983 Feb; 49(1):61. PubMed ID: 6189235
    [No Abstract]   [Full Text] [Related]  

  • 12. [Usefulness of several laboratory tests on prethrombotic status in arterial vascular pathology].
    Arosio E; Lechi C; Pancera P
    Recenti Prog Med; 1989 Jan; 80(1):18-24. PubMed ID: 2523551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in platelet function in patients with arterial hypertension].
    Malý J; Pecka M; Pintérová E; Pidrman V; Bláha M; Siroký O; Jebavý L
    Vnitr Lek; 1995 Jul; 41(7):458-61. PubMed ID: 7571480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory application of radioimmunoassay in the quantitation of molecular markers of hemostatic activation.
    Walenga JM; Fareed J; Hoppensteadt D
    Semin Thromb Hemost; 1984 Oct; 10(4):294-305. PubMed ID: 6240117
    [No Abstract]   [Full Text] [Related]  

  • 15. [Thrombocyte inhibitors in cardiovascular therapy].
    Lüscher TF; Pfisterer M
    Schweiz Rundsch Med Prax; 1990 Sep; 79(39):1132-41. PubMed ID: 2218249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pressure excursions on human platelets. In vitro studies on betathromboglobulin (beta-TG) and platelet factor 4 (PF4) release and on platelet sensitivity to ADP-aggregation.
    Torsellini A; Becucci A; Citi S; Cozzolino F; Guidi G; Lombardi V; Vercelli D; Veloci M
    Haematologica; 1982; 67(6):860-6. PubMed ID: 6186580
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical tests on the diagnosis of thrombosis].
    Yamanaka M
    Nihon Rinsho; 1986 May; 44(5):1076-80. PubMed ID: 2943914
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hemostatic mechanisms and malignant tumors].
    Kase F; Pospísil J; Hlousková D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(6):809-30. PubMed ID: 2419210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet structural physiology: the ultrastructure of adhesion, secretion, and aggregation in arterial thrombosis.
    White JG
    Cardiovasc Clin; 1987; 18(1):13-33. PubMed ID: 3607810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of blood platelets in microcirculatory disorders].
    Scharf RE; Schneider W
    Dtsch Med Wochenschr; 1984 Feb; 109(8):306-13. PubMed ID: 6230218
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.